Influenza surveillance capacity improvements in Africa during 2011-2017.
ANISE
Africa
capacity
influenza
surveillance
Journal
Influenza and other respiratory viruses
ISSN: 1750-2659
Titre abrégé: Influenza Other Respir Viruses
Pays: England
ID NLM: 101304007
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
03
09
2020
accepted:
06
09
2020
pubmed:
6
11
2020
medline:
26
11
2021
entrez:
5
11
2020
Statut:
ppublish
Résumé
Influenza surveillance helps time prevention and control interventions especially where complex seasonal patterns exist. We assessed influenza surveillance sustainability in Africa where influenza activity varies and external funds for surveillance have decreased. We surveyed African Network for Influenza Surveillance and Epidemiology (ANISE) countries about 2011-2017 surveillance system characteristics. Data were summarized with descriptive statistics and analyzed with univariate and multivariable analyses to quantify sustained or expanded influenza surveillance capacity in Africa. Eighteen (75%) of 24 ANISE members participated in the survey; their cumulative population of 710 751 471 represent 56% of Africa's total population. All 18 countries scored a mean 95% on WHO laboratory quality assurance panels. The number of samples collected from severe acute respiratory infection case-patients remained consistent between 2011 and 2017 (13 823 vs 13 674 respectively) but decreased by 12% for influenza-like illness case-patients (16 210 vs 14 477). Nine (50%) gained capacity to lineage-type influenza B. The number of countries reporting each week to WHO FluNet increased from 15 (83%) in 2011 to 17 (94%) in 2017. Despite declines in external surveillance funding, ANISE countries gained additional laboratory testing capacity and continued influenza testing and reporting to WHO. These gains represent important achievements toward sustainable surveillance and epidemic/pandemic preparedness.
Sections du résumé
BACKGROUND
Influenza surveillance helps time prevention and control interventions especially where complex seasonal patterns exist. We assessed influenza surveillance sustainability in Africa where influenza activity varies and external funds for surveillance have decreased.
METHODS
We surveyed African Network for Influenza Surveillance and Epidemiology (ANISE) countries about 2011-2017 surveillance system characteristics. Data were summarized with descriptive statistics and analyzed with univariate and multivariable analyses to quantify sustained or expanded influenza surveillance capacity in Africa.
RESULTS
Eighteen (75%) of 24 ANISE members participated in the survey; their cumulative population of 710 751 471 represent 56% of Africa's total population. All 18 countries scored a mean 95% on WHO laboratory quality assurance panels. The number of samples collected from severe acute respiratory infection case-patients remained consistent between 2011 and 2017 (13 823 vs 13 674 respectively) but decreased by 12% for influenza-like illness case-patients (16 210 vs 14 477). Nine (50%) gained capacity to lineage-type influenza B. The number of countries reporting each week to WHO FluNet increased from 15 (83%) in 2011 to 17 (94%) in 2017.
CONCLUSIONS
Despite declines in external surveillance funding, ANISE countries gained additional laboratory testing capacity and continued influenza testing and reporting to WHO. These gains represent important achievements toward sustainable surveillance and epidemic/pandemic preparedness.
Identifiants
pubmed: 33150650
doi: 10.1111/irv.12818
pmc: PMC8189239
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
495-505Informations de copyright
© 2020 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.
Références
Influenza Other Respir Viruses. 2018 Jan;12(1):30-37
pubmed: 29243402
Influenza Other Respir Viruses. 2021 Jul;15(4):495-505
pubmed: 33150650
PLoS One. 2014 Aug 18;9(8):e105543
pubmed: 25133576
PLoS One. 2016 Apr 27;11(4):e0153003
pubmed: 27119988
Pediatr Infect Dis J. 2015 Jan;34(1):66-72
pubmed: 25093972
BMC Public Health. 2014 Jan 16;14:41
pubmed: 24433304
PLoS One. 2015 Jun 11;10(6):e0128580
pubmed: 26068416
Bull World Health Organ. 2018 Feb 1;96(2):122-128
pubmed: 29403115
PLoS One. 2019 Jul 15;14(7):e0219012
pubmed: 31306466
Vaccine. 2019 May 21;37(23):3002-3005
pubmed: 31027926
BMC Infect Dis. 2016 Dec 13;16(1):757
pubmed: 27964716
Influenza Other Respir Viruses. 2018 Jan;12(1):38-45
pubmed: 29197152
Influenza Other Respir Viruses. 2018 May;12(3):360-373
pubmed: 29210203
Influenza Other Respir Viruses. 2018 Nov;12(6):695-705
pubmed: 30120818
Influenza Other Respir Viruses. 2013 Nov;7(6):1328-35
pubmed: 23551904
BMC Health Serv Res. 2014 May 09;14:209
pubmed: 24886275
J Trop Pediatr. 2012 Apr;58(2):102-6
pubmed: 21653546
Public Health. 2011 May;125(5):247-56
pubmed: 21524774
Vaccine. 2016 Feb 17;34(8):1086-90
pubmed: 26782740
Vaccine. 2019 Aug 14;37(35):5089-5095
pubmed: 31288998
Influenza Other Respir Viruses. 2018 Jan;12(1):46-53
pubmed: 29243406
J Clin Microbiol. 2013 Dec;51(12):4055-9
pubmed: 24088846
MMWR Morb Mortal Wkly Rep. 2020 May 08;69(18):540-544
pubmed: 32379727
Influenza Other Respir Viruses. 2019 Sep;13(5):484-495
pubmed: 31187609
Emerg Infect Dis. 2011 Apr;17(4):619-25
pubmed: 21470450
Influenza Other Respir Viruses. 2019 Mar;13(2):138-147
pubmed: 30596225
J Infect Dis. 2008 Aug 1;198(3):305-11
pubmed: 18558871
PLoS Med. 2016 Mar 24;13(3):e1001977
pubmed: 27011229
J Infect Dis. 2012 Dec 15;206 Suppl 1:S14-21
pubmed: 23169960
Ghana Med J. 2012 Dec;46(4):219-24
pubmed: 23661840